Displaying 1–22 of 22 results for Eric Langer, President/Managing Partner, BioPlan Associates

Sort By Relevance Sort By Date

Pharmaceutical Manufacturing Announces Updated Editorial Advisory Board

(News)

Pharmaceutical Manufacturing is honored to welcome three new editorial advisory board members, as we continue our ongoing quest to keep our brand current and unique.

Investments in Biopharma Production Continue

(Article)

Investments in biologic capability are projected to fuel industry innovation By Steve Kuehn, Executive Content Director, That’s Nice LLC

Downstream Gears Up

(Article)

How modern biopharma is cautiously melding new downstream technology into their processes.

CPhI Launches BioLive Event

(News)

Driving Bioprocessing Efficiency

(Article)

Continuous manufacturing, single-use systems and disposables are pushing industry boundaries.

New Technologies for Downstream Efficiencies

(Article)

Industry sees promise in continuous purification

New Technologies for Downstream Efficiencies

(Article)

Industry sees promise in continuous purification

BRIEF: New Technologies for Downstream Efficiencies

(Article)

Industry study indicates Biopharma sees promise in continuous purification

Seeking Innovation to Solve Persistent Problems

(Article)

Study reveals biopharma's growing demand for effective technologies to drive efficiency and productivity in and cost out of biopharmaceutical processing

Webinar Highlights Emerging Trends in Biopharmaceutical Manufacturing

(News)

November 21 webinar will discuss key results from the 10th annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production.

PAT Adoption Hurdles Remain

(Article)

Despite challenges, mainstream adoption is the future

Focus on Efficiency

(Article)

Single-use, analytical methods and downstream processing at the forefront.

Breaking the Biotech Bottleneck

(Article)

Downstream capacity still lags behind upstream, but shortages are now “acute” rather than “chronic”

Biomanufacturing Shows Signs of Maturity, PAT Adoption

(Article)

Manufacturers are reporting fewer batch failures, adopting PAT and other quality initiatives, and stepping up supply chain quality control.

BioManufacturers Do More Supplier Auditing

(Article)

Quality management is part of an increased focus on productivity and performance.

Demand for Innovation: Disposable Devices Top the List in 2011

(Article)

The demand for improvements in single use, disposable bioprocessing equipment have shot to the top of end-users’ wish list of better, more innovative products in 2011

Biopharma Demands Better Analytical Assays

(Article)

Biosimilars and productivity improvements are driving the market.

Biomanufacturing Morphs

(Article)

In biopharma, budgets are returning and manufacturers are emphasizing innovation, productivity, and cost control.

Single-Use Trends Boosting Adoption

(Article)

The latest industry survey shows application trends, and areas where end users would like to see improvement

Langer: The Future of Biomanufacturing: Towards More, and Better, Therapies

(Article)

Improvements in biomanufacturing will lead to improvements in most everything that matters to industry and consumers, including more products, more variety, more diseases being treated, and more effective therapies.

What's Holding Back Single-Use Bioprocessing?

(Article)

Disposable equipment can now handle complex bioprocessing, but concerns about cost and leachables and extractables remain key issues.

Sort By Relevance Sort By Date